Join to View Full Profile
6431 Fannin StHouston, TX 77030
Phone+1 713-500-6500
Fax+1 713-500-6497
Dr. Jayan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2020 - 2023
University of Missouri Kansas City School of MedicineClass of 2020
Certifications & Licensure
CA State Medical License 2024 - 2026
TX State Medical License 2023 - 2025
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Real-World Immune-Related Adverse Events in Patients With Early Triple-Negative Breast Cancer Who Received Pembrolizumab.Athira Jayan, Jasmine S Sukumar, Benjamin Fangman, Tejal Patel, Akshara Singareeka Raghavendra
JCO Oncology Practice. 2024-10-10 - 1 citationsImmune Checkpoint Inhibitor-induced Myositis.Athira Jayan, Andrew L Mammen, Maria E Suarez-Almazor
Rheumatic Diseases Clinics of North America. 2024-05-01 - Video rhino-laryngoscope-guided bougie insertion through a supraglottic airway device in an unanticipated difficult airway: An alternative to the fiberoptic bronchoscope.Amarjeet Kumar, Gayatri D Sagdeo, Athira Jayan
Journal of Anaesthesiology, Clinical Pharmacology. 2024-03-28
Press Mentions
Study Reports Real-World Pembrolizumab Toxicity in TNBCNovember 6th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
